Published in Genetics and Environmental Business Week, March 16th, 2006
ZYFLO was approved for marketing by the U.S. Food & Drug Administration (FDA) on September 28, 2005 and sales of the drug began in late October 2005.
"The U.S. launch of ZYFLO highlighted a quarter in which we made steady progress in advancing our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.